Financial plays

Profits are up 6.1% at Kerry for H1,

Kerry delivers “solid” H1 with 6% profit hike to €214m

By Shane Starling

Irish dairy and ingredients group Kerry has turned in a”solid” first half of 2011 that saw it increase volumes, weather raw material price hikes, and see success in a “go-to-market” functional ingredient strategy as profits jumped 6.1% on 2010 figures.

DSM on Vitatene, Martek and its investment “shortlist”

Disptaches from Vitafoods Europe 2011

DSM on Vitatene, Martek and its investment “shortlist”

By Shane Starling

DSM’s head of global marketing in human nutrition and health, Gareth Barker, explains why it has bought a carotenoid supplier (approval permitting), how the Martek acquisition is progressing, and why the company is not finished spending yet.

DuPont succeeds in Danisco bid

DuPont succeeds in Danisco bid

By Caroline Scott-Thomas

US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.

DSM reports successful tender offer for Martek

DSM reports successful tender offer for Martek

By Mike Stones

Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...

A solid balance sheet will permit further acquisition activity, Raisio says

Raisio turns in healthy results and promises further acquisitions

By Shane Starling

Finnish ingredients and branded foods player Raisio – the owner of the stanol-cholesterol reduction brand Benecol, will continue seeking acquisitions, it announced in its 2010 financial statement that saw EBIT come in at €19.4m for the year.

It would appear pharma giant Pfizer has gargantuan supplement ambitions as it buys Danish player, Ferrosan

Pfizer acquires Danish food supplements operation

By Shane Starling

Pfizer has acquired the consumer healthcare business of Danish firm Ferrosan for an undisclosed fee in what the pharma giant says, “is an excellent strategic fit that strengthens our presence in dietary supplements”.

Analysts: DuPont Danisco buy-out may end in fire sale

Analysts: DuPont Danisco buy-out may end in fire sale

By Shane Starling

Analysts are saying Danisco could be carved up by its new owner DuPont, which they suggest is most interested in the Danish company’s enzymes for biofuels and that the food side of the business may be jettisoned.

Follow us

Products

View more

Webinars